Kinase inhibition models and their uses

Details Kinase inhibition models and their uses Kinase inhibition models and their uses

2011-06-14

2011-06-14

Nashed, Nashaat T (Department: 1656)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Transferase other than ribonuclease

Reexamination Certificate

active

07960158

ABSTRACT:
The present invention provides a c-Met inhibition model. The invention further provides a method to derive inhibition models for other kinases. The kinase inhibition models of the present invention can be used to design or screen for inhibitors for kinases.

REFERENCES:
patent: 1243596 (2002-09-01), None
patent: WO-2006/086484 (2006-08-01), None
Albrecht et al., “Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase”,J. Med. Chem., 51(10):2879-2882 (2008).
Appelt, K., “Crystal structures of HIV-1 protease-inhibitor complexes”,Persp. Drug Disc. Des., 1(1):23-48 (1993).
Bellon et al., “c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations”,J. Biol. Chem., 283(5):2675-2683 (2008).
Cowan-Jacob et al., “Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia”,Acta Crystal,. D63:80-93 (2007).
Erickson J.W., “Design and structure of symmetry-based inhibitors of HIV-1 protease”,Persp. Drug Disc. Des., 1(1):109-128 (1993).
Griffith et al., “The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain”,Mol. Cell, 13:169-178 (2004).
Hubbard et al., “Crystal structure of the tyrosine kinase domain of the human insulin receptor”,Nature, 372(6508):746-754 (1994).
Huse et al., “The Conformational Plasticity of Protein Kinases”,Cell, 109:275-282 (2002).
Johnson et al., “Active and Inactive Protein Kinases: Structural Basis for Regulation”,Cell, 85:149-158 (1996).
Jones et al., “Improved Methods for Building Protein Models in Electron Density Maps and the Location of Errors in these Models”,Acta. Crystal., A47:110-119 (1991).
Kissinger et al., “Rapid automated molecular replacement by evolutionary search”,Acta Cryst., D55:484-491 (1999).
La Fortelle et al., “Maximum-Likelihood Heavy-Atom Parameter Refinement for Multiple Isomorphous Replacement and Multiwavelength Anomalous Diffraction Methods”,Meth. Enzymol., 276:472-494 (1997).
Lam et al., “Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors”,Science, 263:380-384 (1994).
Mohammadi et al.,“Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism”,Cell, 86:577-587 (1996).
Mol et al., “Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase”,J. Biol. Chem., 279(30):31655-31663 (2004).
Nagar et al., “Crystal Structures of the Kinase Domain of c-Abl in Complex with the Small Molecule Inhibitors PD173955 and Imatinib (STI-571)”,Cancer Res., 62:4236-4243 (2002).
Navaza, J., “Research Papers. AMoRe: an Automated Package for Molecular Replacement”,Acta Cryst., A5O:157-163 (1994).
Otwinowski et al., “Processing of X-Ray Diffraction Data Collected in Oscillation Mode”,Meth. Enymol., 276:307-326 (1997).
Schiering et al., “Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a”,Proc. Nat'l. Acad. Sci. U.S.A., 100(22):112654-12659 (2003).
Schindler et al., “Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase”,Science, 289:1938-1942 (2000).
Schindler et al., “Crystal Structure of Hck in Complex with a Src Family-Selective Tyrosine Kinase Inhibitor”,Mol. Cell, 3:639-648 (1999).
Schubert et al., “Crystal Structure of the Tyrosine Kinase Domain of Colony-stimulating Factor-1 Receptor (cFMS) in Complex with Two Inhibitors”,J. Biol. Chem., 282(6):4094-4101 (2007).
Wang et al., “Structural characterization of autoinhibited c-Met kinase product by coexpression inbacteria with phosphatase”,Proc. Nat'l. Sci. U.S.A., 103(10):3563-3568 (2006).
Wlodawer et al., “Structure-Based Inhibitors of HIV-1 Protease”,Ann. Rev. Biochem., 62:543-585 (1993).
Xu et al., “Crystal Structures of c-Src Reveal Features of Its Autoinhibitory Mechnism”,Mol. Cell, 3:629-638 (1999).

Affiliated with

Also associated with

Rating

Kinase inhibition models and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kinase inhibition models and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibition models and their uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2669597